{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cortex Periplocae", "biological activities", "periplocin", "phytochemistry", "traditional Chinese medicines"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27973416", "DateCompleted": {"Year": "2017", "Month": "04", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "12", "Day": "10"}], "ELocationID": ["1702"], "Language": ["eng"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "21", "Issue": "12", "PubDate": {"Year": "2016", "Month": "Dec", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "A Review on Phytochemistry and Pharmacology of Cortex Periplocae.", "Abstract": {"AbstractText": ["<i>Cortex Periplocae</i>, as a traditional Chinese herbal medicine, has been widely used for autoimmune diseases, especially rheumatoid arthritis. Due to its potential pharmaceutical values, more studies about the biological activities of <i>Cortex Periplocae</i> have been conducted recently. Meanwhile, the adverse reaction of <i>Cortex Periplocae</i> is not a negligible problem in clinic. In this article, we reviewed a series of articles and summarized the recent studies of <i>Cortex Periplocae</i> in the areas of phytochemistry and pharmacology. More than 100 constituents have been isolated and identified from <i>Cortex Periplocae</i>, including steroids, cardiac glycosides, terpenoids, and fatty acid compounds. The crude extracts of <i>Cortex Periplocae</i> and its active compounds exhibit various biological activities, such as cardiotonic effect, anticancer action, and anti-inflammatory effect. This paper aims to provide an overall review on the bioactive ingredients, pharmacological effect, and toxicity of this plant. Furthermore, this review suggests investigating and developing new clinical usages according to the above pharmacological effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. llyangtcm@163.com."}, {"Identifier": [], "Affiliation": "Tianjin Key Laboratory of Phytochemistry and Pharmaceutical Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. llyangtcm@163.com."}], "LastName": "Li", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. zishan826@126.com."}], "LastName": "Li", "ForeName": "Jin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. z.k.ken@263.net."}], "LastName": "Zhou", "ForeName": "Kun", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. hejun673@163.com."}, {"Identifier": [], "Affiliation": "Tianjin Key Laboratory of Phytochemistry and Pharmaceutical Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. hejun673@163.com."}], "LastName": "He", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Material Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou 310036, China. caojun91@163.com."}], "LastName": "Cao", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA. mingruia@umich.edu."}], "LastName": "An", "ForeName": "Mingrui", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. Tcmcyx@126.com."}, {"Identifier": [], "Affiliation": "Tianjin Key Laboratory of Phytochemistry and Pharmaceutical Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. Tcmcyx@126.com."}], "LastName": "Chang", "ForeName": "Yan-Xu", "Initials": "YX"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardiotonic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Cardiotonic Agents"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Feng J.Q., Zhang R.J., Zhou Y., Chen Z.H., Tang W., Liu Q.F., Zuo J.P., Zhao W.M. Immunosuppressive pregnane glycosides from Periploca sepium and Periploca forrestii. Phytochemistry. 2008;69:2716\u20132723. doi: 10.1016/j.phytochem.2008.08.015.", "ArticleIdList": ["10.1016/j.phytochem.2008.08.015", "18835000"]}, {"Citation": "Deng W.P., Cui Y.J., Yang M. Progress on Research of Cortex Periplocae. Acta Univ. Tradit. Med. Sin. Pharmacol. Shanghai. 2012;26:111\u2013115."}, {"Citation": "Guo H., Mao H.P., Pan G.X., Zhang H., Fan G.W., Li W.W., Zhou K., Zhu Y., Yanagihara N., Gao X.M. Antagonism of Cortex Periplocae extract-induced catecholamines secretion by Panax notoginseng saponins in cultured bovine adrenal medullary cells by drug combinations. J. Ethnopharmacol. 2013;147:447\u2013455. doi: 10.1016/j.jep.2013.03.036.", "ArticleIdList": ["10.1016/j.jep.2013.03.036", "23524165"]}, {"Citation": "Gu W., Zhao L.J., Zhao A.G. Effect of Periplogenin on Mast Cell Degranulation and Histamine Release. Chin. Pharm. 2008;19:166\u2013168."}, {"Citation": "Xu L.Q., Lu H.Z., Zhang Y.L. Clinical observation on treatment of 147 cases of chronic congestive heart-failure by bei wujiapi mixture. Yunnan J. Tradit. Chin. Med. Mater. Med. 1998;19:29\u201331."}, {"Citation": "He J., Bo F., Tu Y.R., Azietaku J.T., Dou T., Ouyang H., Chang Y.X., Liu H., Gao X.M. A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study. J. Pharm. Biomed. Anal. 2015;114:292\u2013295. doi: 10.1016/j.jpba.2015.06.008.", "ArticleIdList": ["10.1016/j.jpba.2015.06.008", "26093244"]}, {"Citation": "Cheng C.-F., Lu I., Tseng H.-W., Sun C.-Y., Lin L.-T., Kuo Z.-K., Pan I., Ko C.-H. Antitumor effect of periplocin in TRAIL-resistant human hepatocellular carcinoma cells through downregulation of IAPs. Evid. Based Complement. Altern. Med. 2013;2013:958025. doi: 10.1155/2013/958025.", "ArticleIdList": ["10.1155/2013/958025", "PMC3549389", "23365613"]}, {"Citation": "Zhao L., Shan B., Du Y., Wang M., Liu L., Ren F.-Z. Periplocin from Cortex Periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via \u03b2-catenin/TCF signaling. Oncol. Rep. 2010;24:375\u2013383.", "ArticleIdList": ["20596624"]}, {"Citation": "Sun D., Zhang J., Chen J.T., Bi B., Zhou K., Deng Y.R. Study on Toxicity of Periplocin in Single Administration. J. Toxicol. 2010;24:461\u2013462."}, {"Citation": "Xu X., Ma Z.H., Sun D., Chen J.T., Zhou K., Liu Y. Study on Correlation of the Content of Periplocin with Acute Toxicity of Cortex Periplocae. Chin. J. Pharmacovigil. 2015;12:261\u2013263."}, {"Citation": "Sakuma S., Kawanishi S., Shoji J., Shibata S. Constituents of Chinese crude drug \u201cWujiapi\u201d. I. Studies on the aglycones of steroidal glycosides of pei-wujiapi.(1) Chem. Pharm. Bull. 1968;16:326\u2013331. doi: 10.1248/cpb.16.326.", "ArticleIdList": ["10.1248/cpb.16.326", "5677607"]}, {"Citation": "Itokawa H., Xu J.P., Takeya K., Watanabe K., Shoji J. Studies on chemical constituents of antitumor fraction from Periploca sepium. II. Structures of new pregnane glycosides, periplocosides A, B and C. Chem. Pharm. Bull. 1988;36:982\u2013987. doi: 10.1248/cpb.36.982.", "ArticleIdList": ["10.1248/cpb.36.982", "3409416"]}, {"Citation": "Itokawa H., Xu J.P., Takeya K. Studies on chemical constituents of antitumor fraction from Periploca sepium. IV. Structures of new pregnane glycosides, periplocosides D, E, L and M. Chem. Pharm. Bull. 1988;36:2084\u20132089. doi: 10.1248/cpb.36.2084.", "ArticleIdList": ["10.1248/cpb.36.2084", "3240444"]}, {"Citation": "Itokawa H., Xu J., Takeya K. Studies on chemical constituents of antitumor fraction from Periploca sepium. V. Structures of new pregnane glycosides, periplocosides J, K, F and O. Chem. Pharm. Bull. 1988;36:4441\u20134446. doi: 10.1248/cpb.36.4441.", "ArticleIdList": ["10.1248/cpb.36.4441", "3246012"]}, {"Citation": "Ishizone H., Sakuma S., Kawanishi S., Shoji J. Constituents of Chinese Crude Drug \u201cWujiapi\u201d. VII. On the Structure of Glycoside E of Bei-Wujiapi. Chem. Pharm. Bull. 1972;20:2402\u20132406. doi: 10.1248/cpb.20.2402.", "ArticleIdList": ["10.1248/cpb.20.2402", "5544368"]}, {"Citation": "Itokawa H., Xu J., Takeya K. Studies on chemical constituents of antitumor fraction from Periploca sepium BGE. I. Chem. Pharm. Bull. 1987;35:4524\u20134529. doi: 10.1248/cpb.35.4524.", "ArticleIdList": ["10.1248/cpb.35.4524", "3442886"]}, {"Citation": "Xu J., Takeya K. Pregnane glycosides from an antitumour fraction of Periploca sepium. Phytochemistry. 1988;27:1173\u20131179."}, {"Citation": "Sakuma S., Kawanishi S., Shoji J. Constituents of the chinese crude drug \u201cWujiapi\u201d. IX. Structure of glycoside H2, a potentiator of NGF-mediated nerve fiber outgrowth. Chem. Pharm. Bull. 1980;28:163\u2013168. doi: 10.1248/cpb.28.163.", "ArticleIdList": ["10.1248/cpb.28.163", "7363368"]}, {"Citation": "Umehara K., Sumii N., Satoh H., Miyase T., Kuroyanagi M., Ueno A. Studies on differentiation inducers. V. Steroid glycosides from periplocae radicis cortex. Chem. Pharm. Bull. 1995;43:1565\u20131568. doi: 10.1248/cpb.43.1565.", "ArticleIdList": ["10.1248/cpb.43.1565", "7586083"]}, {"Citation": "Shoji J., kawanishi S., Sakuma S., Shibata S. Studies on the Chemical Constituents of Chinese Drug \u201cWujiapi\u201d. Chem. Pharm. Bull. 1967;15:720\u2013723. doi: 10.1248/cpb.15.720.", "ArticleIdList": ["10.1248/cpb.15.720", "6076778"]}, {"Citation": "Xu J., Takeya K., Itokawa H. Pregnanes and cardenolides from Periploca sepium. Phytochemistry. 1990;29:344\u2013346. doi: 10.1016/0031-9422(90)89071-G.", "ArticleIdList": ["10.1016/0031-9422(90)89071-G"]}, {"Citation": "Wang L., Yin Z.-Q., Zhang Q.-W., Zhang X.-Q., Zhang D.-M., Liu K., Li Y.-L., Yao X.-S., Ye W.-C. Five new C21 steroidal glycosides from Periploca sepium. Steroids. 2011;76:238\u2013243. doi: 10.1016/j.steroids.2010.11.004.", "ArticleIdList": ["10.1016/j.steroids.2010.11.004", "21110993"]}, {"Citation": "Zhang H.Y., He Q.H., Tong S.S., Yu J.N., Xu X.M. Advances in Research on Active Constituents from Periplocae Cortex and Their Pharmacological Activities. Prog. Pharm. Sci. 2013;37:449\u2013453."}, {"Citation": "Sakuma S., Ishizone H., Kasai R., Kawanishi S., Shoji J. Constituents of Chinese crude drug \u201cwujiapi\u201d. III. On the structure of glycoside G and K of bei-wujiapi. Chem. Pharm. Bull. 1971;19:52\u201359. doi: 10.1248/cpb.19.52.", "ArticleIdList": ["10.1248/cpb.19.52", "5544368"]}, {"Citation": "Li L., Zhang L., Gao J., Tong L. Fatty acid from the Roots of Periploca sepium. Chin. Tradit. Herb. Drugs. 2008;39:1306\u20131307."}, {"Citation": "Shi Q.H., Ma Y.M., Qin H.Q. Chemical Components and Insecticidal Activity of Essential Oil in Periploca sepium Root Bark to Schizaphis graminum. Acta Bot. Boreal. Occident. Sin. 2006;26:620\u2013623."}, {"Citation": "Tong L. Master\u2019s Thesis. Shenyang Pharmaceutical University; Shenyang, China: 2007. Studies on Chemical Components and Method of Quality Assessment of Xiangjiapi."}, {"Citation": "Wang J., Liu H., Zhao J., Gao H., Zhou L., Liu Z., Chen Y., Sui P. Antimicrobial and antioxidant activities of the root bark essential oil of Periploca sepium and its main component 2-hydroxy-4-methoxybenzaldehyde. Molecules. 2010;15:5807\u20135817. doi: 10.3390/molecules15085807.", "ArticleIdList": ["10.3390/molecules15085807", "PMC6257732", "20736908"]}, {"Citation": "China Pharmacopoeia Committee . Pharmacopoeia of the People\u2019s Republic of China. Chemical Industry Press; Beijing, China: 2015. pp. 257\u2013258. 1st Division."}, {"Citation": "Wang L., Yin Z.Q., Zhang L.H., Ye W.C., Zhang X.Q., Shen W.B., Zhao S.X. Chemical constituents from root barks of Periploca sepium. China J. Chin. Mater. Med. 2007;32:1300\u20131302.", "ArticleIdList": ["17879730"]}, {"Citation": "Mitsuhashi H., Tomimoto K. Components of Periploca aphylla. Constituents of Asclepiadaceae plants. XXX. Shoyakugaku Zasshi. 1971;25:7\u201310."}, {"Citation": "Guo H.-L., Zhou J.-Y. Study on the chemical constituents of Periploca calophylla. Chin. Pharm. J. Beijing. 2003;38:497\u2013498."}, {"Citation": "Shi Q.H., Ma Y.M. Structural Analysis on Four Compounds in Root Bark from Periploca sepium. J. Northwest For. Univ. 2007;22:132\u2013135."}, {"Citation": "V\u00e1zquez L.H., Palazon J., Navarro-Oca\u00f1a A. The Pentacyclic Triterpenes \u03b1,\u03b2-amyrins: A Review of Sources and Biological Activities. Phytochemicals. 2012;23:487\u2013502."}, {"Citation": "Wang L.-P., Liu J.-L. Advances in studies on chemical constituents from Cortex Periplocae and its pharmacological effects. Chin. Tradit. Herb. Drugs. 2009;3:493\u2013496."}, {"Citation": "Ma W.Z., Ling T.J., Zhang Y.H., Lin L.D. Chemical Constituents from Nauclea officinalis. J. Trop. Subtrop. Bot. 2004;13:167\u2013170."}, {"Citation": "Sholichin M., Yamasaki K., Kasai R., Tanaka O. 13C nuclear magnetic resonance of lupane-type triterpenes, lupeol, betulin and betulinic acid. Chem. Pharm. Bull. 1980;28:1006\u20131008. doi: 10.1248/cpb.28.1006.", "ArticleIdList": ["10.1248/cpb.28.1006"]}, {"Citation": "Wang N., Wang J.-H., Cheng J., Li X. Chemical constituents of Pyrrosia petiolosa (Christ) Ching. J. Shenyang Pharm. Univ. 2003;6:425\u2013427."}, {"Citation": "Della Greca M., Fiorention A., Monaco P., Previtera L. Cycloartane triterpenes from Juncus effusus. Phytochemistry. 1994;35:1017\u20131022. doi: 10.1016/S0031-9422(00)90659-9.", "ArticleIdList": ["10.1016/S0031-9422(00)90659-9", "7765629"]}, {"Citation": "Sakuma S., Kawanishi S., Shoji J. Constituents of Chinese Crude Drug \u201cwujiapi\u201d VIII. Chem. Pharm. Bull. 1977;25:2055\u20132060."}, {"Citation": "Wang L.F., Shan B.E., Liu L.H., Ren F.Z., Shan T.Q. Effect of baohuoside I from Cortex periplocae on proliferation and apoptosis of esophageal carcinoma cells. Tumor. 2009;29:123\u2013126."}, {"Citation": "Zhang Y.H., Wang F.P. Recent advances of chemical constituents of Periploca plants. Nat. Prod. Res. Dev. 2003;15:157\u2013161."}, {"Citation": "Li J.N., Zhao L.Y., Yu J., Gao Y., Deng Y.R. Chemical constituents of the root barks of Periploca sepium. Chin. Tradit. Pat. Med. 2010;32:1552\u20131556."}, {"Citation": "Bi Z.M., Li J., Zhou J.J., Liu L.J. Chemical Constituents in the Root Barks of Periploca sepium. Pharm. Clin. Res. 2011;19:521\u2013522."}, {"Citation": "Yu L.N. Master\u2019s Thesis. Jilin Unibersity; Jilin, China: 2009. Studies on Chemical Constituents of Periploca Sepium Bge."}, {"Citation": "Chen S.H., Yang J.S., Ren F.Z., Liu G.S., Zhang J., Shan B.E., Li N. Antitumor active constituents of Cortex Periplocae. Chin. Tradit. Herb. Drugs. 2006;37:519\u2013520."}, {"Citation": "Kawanishi S., Sakuma S., Okino H., Shoji J. Constituents of Chinese Crude Drug \u201cWujiapi\u201d. IV. On the Structure of a New Acetylbiose from Steroidal Glycosides of Bei-Wujiapi. Chem. Pharm. Bull. 1972;20:93\u201396. doi: 10.1248/cpb.20.93.", "ArticleIdList": ["10.1248/cpb.20.93"]}, {"Citation": "Bo F., Dou T., Wang X., Donkor P.O., Ouyang H., Chang Y., Tu Y., Gao X., He J. A validated LC-MS/MS method for determination of periplogenin in rat plasma and its application in pharmacokinetic study. J. Chromatogr. B. 2015;990:80\u201383. doi: 10.1016/j.jchromb.2015.03.017.", "ArticleIdList": ["10.1016/j.jchromb.2015.03.017", "25864008"]}, {"Citation": "Tokiwa T., Harada K., Matsumura T., Tukiyama T. Oriental medicinal herb, Periploca sepium, extract inhibits growth and IL-6 production of human synovial fibroblast-like cells. Biol. Pharm. Bull. 2004;27:1691\u20131693. doi: 10.1248/bpb.27.1691.", "ArticleIdList": ["10.1248/bpb.27.1691", "15467222"]}, {"Citation": "Zhu Y.-N., Zhao W.-M., Yang Y.-F., Liu Q.-F., Zhou Y., Tian J., Ni J., Fu Y.-F., Zhong X.-G., Tang W. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo. J. Pharmacol. Exp. Ther. 2006;316:662\u2013669. doi: 10.1124/jpet.105.093732.", "ArticleIdList": ["10.1124/jpet.105.093732", "16204471"]}, {"Citation": "Wan J., Zhu Y.-N., Feng J.-Q., Chen H.-J., Zhang R.-J., Ni J., Chen Z.-H., Hou L.-F., Liu Q.-F., Zhang J. Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions. Int. Immunopharmacol. 2008;8:1248\u20131256. doi: 10.1016/j.intimp.2008.05.001.", "ArticleIdList": ["10.1016/j.intimp.2008.05.001", "18602071"]}, {"Citation": "Du Y.Y., Liu S.B., Liu X., Shan B.E. Effect of Periplocin Extracted from Cortex Periplocae on Proliferation of Colorectal Cancer Cell SW480 in Vitro and in Vivo. Carcinog. Teratog. Mutag. 2009;21:181\u2013184."}, {"Citation": "Liu S.B., Du Y.Y., Liu X., Shan B.E. Inhibitory Effect and Mechanisms of Periplocin Extracted from Cortex Periplocae on Tumor Formation Activity of SW480 Cells in Nude Mice. Carcinog. Teratog. Mutag. 2009;21:344\u2013347."}, {"Citation": "Zhang L.J., Lu G., Zhang Y.J., Liu G.S., Shan B.E. Periplocin of cortex periplocae inhibits Stat3 signaling and induces apoptosisin human hepato cellular carcinomacell line SMMC-7721. Acta Acad. Med. Mil. Tert. 2008;30:1448\u20131451."}, {"Citation": "Zhao L.M., Shan B.E., Ai J., Ren F.Z., Lian Y.S., Song X.T. Inhibitory effects of periplocin from Cortex Periplocae on proliferation of human esophageal carcinoma TE-13 cells. Tumor. 2008;28:203\u2013206."}, {"Citation": "Zhang Y.J., Lu G., Zhang L.J., Shan B.E. The Relationship between Suppressive Effects of Cortex Periplocae on BT-549 Cells and Expression of p16 and p27. Carcinog. Teratog. Mutag. 2008;20:216\u2013219."}, {"Citation": "Li Y.H., Gao X.M., Zhang B.L., Xu Q., Liu H., Pan G.X. Effect of the Chinese medicine xiangjiapi on cardiac function of isolated hearts. J. Liaoning Coll. Tradit. Chin. Med. 2005;47:396\u2013397."}, {"Citation": "Ma L., Ji Y.S., Han J., Li F., Wang Y. Effect of glucoperiplocymarin on left ventricular structure and function in chronic heart failure rats by color doppler-echocardiography. J. Tianjin Univ. Tradit. Chin. Med. 2008;27:81\u201383."}, {"Citation": "Xie Z., Askari A. Na+/K+-ATPase as a signal transducer. Eur. J. Biochem. 2002;269:2434\u20132439. doi: 10.1046/j.1432-1033.2002.02910.x.", "ArticleIdList": ["10.1046/j.1432-1033.2002.02910.x", "12027880"]}, {"Citation": "Zhao Y.C., Shi B.J., Hu Z.N. The insecticidal activity of periplocoside NW. Chin. Bull. Entomol. 2008;6:950\u2013952."}, {"Citation": "Hui Y.R., Li Y., Yang H. Periploca Methyl Alcohol Extraction Insect Disinfestation Active Ingredient Separation and Determination research. J. Yanan Univ. 2014;33:42\u201344."}, {"Citation": "Shi Q.H., Ma Y.M., Qin H.Q. Preliminary Study on Chemical Composition and Insectieidal Activity of Root Bark from Periploca sepium. Acta Agric. Boreal. Occident. Sin. 2005;14:141\u2013144."}, {"Citation": "Sun R., Bao Z.H., Huang W., Lv L.L., Zhang Z.P., Ren H.Y. Experimental Comparison Study on Mice\u2019s Acute Toxicity of Different Composition in Cortex Periplocae. Chin. J. Pharmacovigil. 2010;7:579\u2013584."}, {"Citation": "Xu X., Zhou K., Qu C.Q. Experimental study on acute toxicity and accumulative toxicity of Cortex Periplocae. Jiangsu J. Tradit. Chin. Med. 2008;40:117\u2013118."}, {"Citation": "Tong L. RP-HPLC determination of isovanillin, periplocin and 4-methoxy salicylaldehyde in root bark of Cortex Periplocae. Chin. J. Pharm. Anal. 2009;29:961\u2013963."}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "11", "Day": "1"}, {"Year": "2016", "Month": "11", "Day": "30"}, {"Year": "2016", "Month": "12", "Day": "1"}, {"Year": "2016", "Month": "12", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["27973416", "PMC6272874", "10.3390/molecules21121702", "molecules21121702"]}}], "PubmedBookArticle": []}